XML 174 R7.htm IDEA: XBRL DOCUMENT v3.24.3Close
Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:    
Net income $ 771 $ 725
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,083 1,042
Deferred income taxes 238 94
Loss on divestitures 0 12
Loss (gain) on equity securities 10 (56)
Loss (gain) on indexed debt securities (14) 52
Pension contributions (5) (30)
Changes in other assets and liabilities:    
Accounts receivable and unbilled revenues, net 145 528
Inventory 19 63
Taxes receivable (75) (47)
Accounts payable (247) (443)
Current regulatory assets and liabilities (91) 1,173
Non-current regulatory assets and liabilities (553) (71)
Other current assets and liabilities (25) (41)
Other non-current assets and liabilities 31 59
Other operating activities, net (37) 9
Net cash provided by operating activities 1,250 3,069 Close
Cash Flows from Investing Activities:    
Capital expenditures (2,501) (3,323)
Proceeds from divestitures 0 145
Other investing activities, net (58) (12)
Net cash used in investing activities (2,559) (3,190) Close
Cash Flows from Financing Activities:    
Decrease in short-term borrowings, net (2) (14)
Payments of commercial paper, net (520) (1,496)
Proceeds from long-term debt and term loans, net 2,757 5,574
Payments of long-term debt and term loans, including make-whole premiums (963) (2,613)
Payment of debt issuance costs (25) (50)
Payment of dividends on Common Stock (384) (359)
Payment of dividends on Preferred Stock 0 (49)
Proceeds from issuance of Common Stock, net 494 0
Redemption of Series A Preferred Stock 0 (800)
Other financing activities, net (28) (25)
Net cash provided by (used in) financing activities 1,329 168 Close
Net Increase in Cash, Cash Equivalents and Restricted Cash 20 47 Close
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 109 91
Cash, Cash Equivalents and Restricted Cash at End of Period $ 129 $ 138